GlassScriptPhysician profile
Matthew Yanoff
NPI 1649711920
$9,309.06
in general payments reported to CMS, 2019-2025
10 companies · $2,149 in 2025
The $2,149 reported for 2025 was more than what 80% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,530 · 2024: $3,630 · 2025: $2,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,836 · Travel and Lodging: $2,898 · Food and Beverage: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,836.21 |
| Travel and Lodging | $2,897.75 |
| Food and Beverage | $1,575.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,103.66 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $554.49 | 2024 | Advantagerib |
| Davol INC. | $226.08 | 2023-2025 | Phasix Mesh |
| Ethicon US, LLC | $210.30 | 2024-2025 | Echelon Flex, Stratafix, Enseal |
| Boston Scientific Corporation | $62.32 | 2024-2025 | Spyglass Discover |
| Haemonetics Corporation | $48.77 | 2023-2024 | Teg6s Hemostasis System |
| Kerecis Limited | $44.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $23.31 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Teleflex LLC | $18.17 | 2024 | Titan Sgs |
| Smith+Nephew, INC. | $17.20 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Yanoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.